Derynck Mika K — SEC Form 4 filings

SEC reporting owner CIK 1865125. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-06.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-15 to 2026-08-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)Director51 leg · 158,795 sh · $9,561,58712

Form 4 filings — Derynck Mika K

FiledFormIssuerReported transactionsSource
2026-08-064Enliven Therapeutics, Inc. (ELVN)Option exercise (M): 87,373 @ $2.48 · Option exercise (M): 27,567 @ $25.28 · Option exercise (M): 23,364 @ $14.85 · Option exercise (M): 20,491 @ $22.47 · Sale (S): 158,795 @ $60.21 · Option exercise (M): 87,373 (derivative) @ $0 · +3 moreEDGAR
2026-02-174Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 17,126 (derivative) @ $0EDGAR
2025-02-104Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 20,491 (derivative) @ $0EDGAR
2024-02-204/AEnliven Therapeutics, Inc. (ELVN)Grant/award (A): 23,364 (derivative) @ $0EDGAR
2024-02-154Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 16,835 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1865125 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →